Breast cancer

Home > Series index > Breast cancer

  Acrobat Reader

Breast cancer: an overview
In the first of two articles, Sandra Melville and Lucy Heycock outline the pathology of breast cancer and the role pharmacists can play in prevention and patient support
PDF 80K

Pharmaceutical Journal 2007;279:299-302 (15 September 2007)

Treatment of early breast cancer
In a second article on breast cancer, Sandra Melville and Lucy Heycock give an insight into the use of chemotherapy, hormonal therapy and the monoclonal antibody trastuzumab, and describe how these fit in to an overall breast cancer treatment plan
PDF 80K

Pharmaceutical Journal 2007;279:357-360 (29 September 2007)

Risk factors for developing breast cancer

Age Incidence increases from one in 900 in those under 30 years old to one in 10 in those over 85 years.

Oestrogen therapy Oral contraceptives slightly increase the risk of breast cancer. Hormone replacement therapy increases the risk of breast cancer and decreases sensitivity of mammography.

Obesity Women who are obese, particularly post menopause, are at increased risk. Adipose tissue is the main body source of oestrogen after menopause.

Menstrual and pregnancy history Early menarche, late menopause, fewer pregnancies and shorter duration of breastfeeding are all associated with increased risk.

Race Variations are seen with age and race. In women under 40 years old, Caucasian women are more likely than black or Asian women to develop breast cancer, while in women over 40 years black women are at increased risk compared with Caucasian or Asian women. Asian women of all ages are at a decreased risk.

Family history A small proportion of breast cancers have a strong genetic link. Carrying the BRCA1 or BRCA2 gene mutation leads to a 50–80 per cent chance of developing breast cancer.

Height at age 14 Women who were taller than 165cm at the age of 14 years are at increased risk and those under 150cm at the age of 14 years are at decreased risk. (Women in between these heights are at average risk.)

Birth weight Women who weighed over 4.43kg at birth are at increased risk and those weighing less than 3.18kg are at decreased risk.

Socio-economic status There is a positive correlation between risk and socio-economic status — those of higher status are at greater risk.

Geographical location Women in urban areas are at higher risk than those in rural areas.

RESOURCES

Overview and treatment of early disease
Hospital Pharmacist 2004

Million Women Study
The Lancet 2005


Breakthrough breast cancer
Information packs for health professionals
website www.breakthrough.org.uk

Breakthrough Cancer Care
Information packs for health professionals
website www.breastcancercare.org.uk

Breakthrough Generations a major study into the causes of breast cancer, including over 100,000 UK women
website www.breakthroughgenerations.org.uk

Institute of cancer care
website www.icr.ac.uk

NHS cancer screening programmes
website www.cancerscreening.nhs.uk

The contents of the Pharmaceutical Journal, associated publications and all PDF files are the property of the Royal Pharmaceutical Society. See Copyright for our rights.

Photocopies
Photocopies of articles can be ordered from the Society’s library (library@rpsgb.org); for details click here

Reprints
Details on multiple reprints of the original articles are here

Back to Top


©The Pharmaceutical Journal